...
首页> 外文期刊>Journal of clinical laboratory analysis. >Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.
【24h】

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

机译:单核细胞化疗蛋白-1(MCP-1)和白细胞介素-8(IL-8)的尿液水平和2型糖尿病肾病患者肾损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the correlation among the levels of urinary monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), hyperglycemia, and renal injuries in patients with type 2 diabetic nephropathy. The levels of urinary MCP-1, IL-8, protein excretion, blood urea nitrogen (BUN), serum creatinine (s-Cr), glycohemoglobin A1c (HbA1c), and fasting plasma glucose (FPG) were measured in 24 patients with type 2 diabetic nephropathy and 14 healthy adults as controls. Diabetic nephropathy was classified into three stages: stage 1 = normoalbuminuric, stage 2 = microalbuminuric, and stage 3 = macroalbuminuric. All of the patients showed normal ranges in renal function tests. Levels of urinary MCP-1 in all patients with diabetic nephropathy were significantly higher than those in healthy adults (P < 0.05). The levels of urinary MCP-1 in patients with diabetic nephropathy increased gradually according to the clinical stage of this disease. In contrast, the levels of urinary IL-8 in patients with diabetic nephropathy increased in stages 2 and 3. There was a significant correlation between the levels of urinary IL-8 and those of HbA1c. High glucose may stimulate MCP-1 and/or IL-8 production and their excretion into the urine independently of the phases or pathological lesions of this disease. It appears that IL-8 increased in the early stage of diabetic nephropathy, and MCP-1 increased in the advanced stage of this disease. It was concluded that measurement of urinary MCP-1 and IL-8 may be useful for evaluating the degree of renal injuries in patients with type 2 diabetic nephropathy. Copyright 2002 Wiley-Liss, Inc.
机译:我们研究了患有2型糖尿病肾病患者的尿单核细胞化疗化学蛋白-1(MCP-1)和白细胞介素-8(IL-8),高血糖和肾损伤之间的相关性。在24例患者中测量尿MCP-1,IL-8,蛋白排泄,血尿尿素氮(BUN),血清肌酐A1C(S-CR),甘油杂环蛋白A1C(HBA1C)和空腹血糖(FPG)的水平2个糖尿病肾病和14名健康成人作为对照。糖尿病肾病被分为三个阶段:第1阶段=正常白蛋白,第2阶段=微白蛋白和阶段3 =大蛋白酶。所有患者在肾功能测试中显示出正常范围。所有糖尿病肾病患者的尿MCP-1水平明显高于健康成人(P <0.05)。患有糖尿病肾病患者的尿MCP-1水平根据该疾病的临床阶段逐渐增加。相比之下,患有糖尿病肾病患者的尿IL-8水平增加2和3.尿IL-8水平与HBA1C的患者之间存在显着相关性。高葡萄糖可以独立于该疾病的阶段或病理病变,刺激MCP-1和/或IL-8的产生及其排泄到尿液中。似乎IL-8在糖尿病肾病早期增加,MCP-1在这种疾病的晚期阶段增加。结论是尿MCP-1和IL-8的测量可用于评估2型糖尿病肾病患者的肾损伤程度。版权所有2002 Wiley-Liss,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号